This famous perfume entrepreneur sold her name to Estée Lauder. It's her only regret

Jo Malone CBE says her biggest regret after selling Jo Malone London to Estée Lauder in 1999 was surrendering the rights to use her own name, a restriction that has forced her later ventures to use only her first name; she argues the law should change because such sales can act as lifelong non‑competes. UK lawyers note that selling a business typically transfers goodwill and name rights and that contractual covenants and passing‑off rules bar founders like Karen Millen and Elizabeth Emanuel from reusing their names, while U.S. sellers face similar contracts but may have additional 'right of publicity' protections; experts urge founders to negotiate name‑use carve‑outs or watered‑down restrictions before a sale. The episode highlights a practical M&A risk: eponymous brands carry legal and valuation consequences that buyers and sellers must explicitly address during deal structuring to avoid post‑sale limitations on founders’ future businesses.

Analysis

Jo Malone founded Jo Malone London in 1990 and sold it to Estée Lauder nine years later (1999), a transaction that made her a millionaire but included the transfer of goodwill and exclusive rights to use her full name; she says that restriction remains her primary regret and has constrained subsequent businesses to use only her first name (Jo Loves, Jo Vodka). British IP and commercial-law specialists quoted in the article (Simon Barker, Freeths) explain that sale agreements typically convey name rights and that “passing off” and contractual covenants prevent founders from reusing their names when doing so would cause consumer confusion. The article cites precedent—Karen Millen (2004), Elizabeth Emanuel, and Bobbi Brown (sale to Estée Lauder in 1995)—to show courts will enforce these rights and that the U.K. lacks a broad right-of-publicity comparable to the U.S., limiting founders’ protections post-sale. For M&A and valuation, the story highlights a material deal risk: exclusive name assignments can function as de facto lifelong non-competes, reducing founders’ future entrepreneurial optionality and altering buyer/seller leverage; while founders can seek “watered-down” restrictions or carve-outs, sellers should expect price trade-offs when insisting on retained name use.

Key Decisions for Investors

• Acquirers should demand explicit, transferable name and trademark assignments in acquisition agreements and budget for enforcement and integration costs, because exclusive name rights materially reduce post‑sale founder competition
• Founders and sell‑side advisors should negotiate time‑limited, product‑ or geography‑limited carve‑outs or licensed use of their names and quantify the price trade‑off rather than conceding lifelong restrictions
• Due diligence for consumer/eponymous brand deals should model the valuation impact of excluding founder name rights and stress‑test scenarios where the founder launches similarly branded ventures using variants of their name
• Monitor U.K. litigation and any legislative discussion referenced by practitioners about non‑competes and publicity rights, since shifts in precedent or law would change enforcement risk and post‑deal competitive dynamics